RBR-37jpt3已完成4 期
A Randomized single-blinded, parallel group and unicentric Phase IV Clinical Study of non-inferiority, comparing the drug Lysine Clonixinate (Dolamin®) and Ibuprofen (Advil®) in reducing acute pain related to tendinopathy in patients
CREB-Centro de Reumatologia e Ortopedia Botafogo Sociedade Simples LTDA0 个研究点开始时间: 2014年9月16日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 65Y(—)
入选标准
- •Volunteers be carrying from acute pain related to tendinopathy (tendinitis, tenosynovitis and bursitis of the shoulders, wrists / hands, knees and ankles / feet and require immobilization;
- •age between 18 and 65 (sixty five) years; Indicate, in max, grade 7 in the Visual Analogue Scale (VAS) of pain; Having signed and dated the 'Informed of Consent Form' (ICF) specified for this study, prior to any participation in procedures related to it.
排除标准
- •None of the patients included in this study should be carrying from acute pain related to tendinopathy at the hip; having a history of asthma or bronchospasm, nasal polyps, allergic reactions and / or induced by acetylsalicylic acid (aspirin) or other anti-inflammatory drugs; history of gastrointestinal bleeding due to the use of NSAIDs; is receiving treatment with other anti-inflammatory drugs, corticosteroids or analgesics; Is receiving treatment with oral anticoagulants, ticlopidine, heparin and thrombolytics; be pregnant and / or lactating; be hypersensitive (allergic) to any of the components of the formula;
- •8. Be a regular user of alcohol and barbiturates; have hepatic or renal impairment.
研究者
相似试验
进行中(未招募)
不适用
A Clinical study to evaluate the efficacy of Investigational product for the percentage reduction of lesions in patients with Acne vulgarisCTRI/2018/09/015735Atrimed Pharmaceuticals Pvt Ltd20
已完成
不适用
Effects of medical qigong for human body in short and medium termJPRN-UMIN000046305Ebisu Plastic Surgery / Beauty Clinic30
进行中(未招募)
1 期
Randomised, double-blind, parallel group, equivalence, multicentre phase III trial to compare the efficacy, safety and pharmacokinetics of HD201 to Herceptin® in patients with HER2+ early breast canceron-metastatic, unilateral, newly diagnosed, operable early breast cancer (EBC) of clinical stage II and III including inflammatory breast cancer.EUCTR2016-004019-11-ESPrestige BioPharma Pte Ltd500
尚未招募
2 期
Clinical study of Unani drug in comparison to conventional drug in the treatment of vitiligo (white patches)CTRI/2019/04/018669Central Research Institute of Unani Medicine
进行中(未招募)
1 期
AN EQUIVALENCE TRIAL TO COMPARE THE EFFICACY, SAFETY, PHARMACOKINETICS AND IMMUNOGENICITY OF HD204 TO AVASTIN® IN PATIENTS WITH LUNG CANCER.on-squamous Non-small Cell Lung Cancer (nsNSCLC)MedDRA version: 20.0Level: LLTClassification code 10079440Term: Non-squamous non-small cell lung cancerSystem Organ Class: 100000004864EUCTR2017-005175-78-LVPrestige BioPharma Limited592
